Skip to content

    Recently Viewed

      Listening...

      A male scientist in protective glasses and a Johnson & Johnson lab coat writing on a clear whiteboard

      Media Center

      Catch up on the latest Johnson & Johnson news and download the J&J logo and media assets here.

      At Johnson & Johnson our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated and cured, treatments are smarter and less invasive and solutions are personal.

      Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow. We will combine our science and technology with our determination to create a powerful force of care ... and profoundly impact health for humanity.

      Highlighted press releases

      Financial
      Lede- Questions Investors Ask About Johnson & Johnson- J&J WHQ

      Johnson & Johnson Reports Q4 and Full-Year 2023 Results

      Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2023.
      Corporate
      cancer cell

      Johnson & Johnson to Acquire Ambrx, Advancing Next Generation Antibody Drug Conjugates to Transform the Treatment of Cancer

      Portfolio of Clinical and Preclinical Programs, Including Lead Product Candidate ARX517, a Prostate-Specific Membrane Antigen (PSMA)-Targeting Antibody Drug Conjugate (ADC), Strengthens Johnson & Johnson’s Commitment to Oncology Innovation Novel Technology Platform Sets Stage for the Development of Next Generation ADCs and Targeted Oncologic Therapeutics

      Contact Global Media Relations

      Journalists please use the following Johnson & Johnson media relations contacts for inquiries.

      We recommend that if you are on deadline—or if it is after business hours—put ON DEADLINE in the subject of your email. It is also helpful if you are as specific as possible with your request.

      Office Telephone: 732-524-1090

      media-relations@its.jnj.com
      A person using their smartphone to view the Our Credo page on the Johnson & Johnson website

      Media interviews

      Johnson & Johnson has a state-of-the-art production studio available for media interviews. We have an HD-SDI fiber optic cable connection to the All Mobile Video Gateway in Weehawken, New Jersey. From All Mobile Video Gateway, we can be patched to just about anywhere in the United States accessible by fiber optic cable. Our studio can also send our signal to an AMV uplink which allows for international video connections.

      All press releases

      Press Releases

      Listening...

      1,899 Results
      Date
      Topic
      1,899 results

      In the Media?

      Sign up for Johnson & Johnson company news and press releases delivered right to your inbox.

      Email us at RA-RNDUS-MediaRelati@ITS.JNJ.com.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.